NUOPTII

H. Lundbeck A/S

Application Filed: 2017-10-18

Trademark Application Details

Status

732

Live/Pending

THIRD EXTENSION - GRANTED

Research	OneLook Acronym Finder
Serial Number	87650626
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Claudia A. Smith
Attorney Name	Claudia A. Smith
Attorney Docket Number	1101391-0248
Law Office Assigned	M40
Employee Name	SIRIGNANO, EMMA MARIE

Timeline

2017-10-18	Application Filed
2018-05-01	Published for Opposition
2018-06-26	Location: INTENT TO USE SECTION
2019-12-03	Status: Live/Pending
2019-12-05	Transaction Date

Trademark Applicants & Owners

Owner:	H. Lundbeck A/S
Entity Statement	aktieselskab (a/s)
Address	Ottiliavej 9 2500 Valby DK
Legal Entity Type
Legal Entity State	DK

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CLAUDIA A. SMITH
WHITE & CASE LLP
TRADEMARK DEPARTMENT
1221 AVENUE OF THE AMERICAS
NEW YORK NY 10020

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044

Type Code	Type
GS0051	Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Type Code

Type

GS0051

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2017-10-21	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2017-10-27	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2018-01-26	3 DOCK D:Assigned to Examiner
TEAS VOLUNTARY AMENDMENT RECEIVED	2018-01-31	4 PARI I:Incoming Correspondence
PRIORITY ACTION WRITTEN	2018-02-01	5 CPRA R:Renewal
PRIORITY ACTION E-MAILED	2018-02-01	6 GPRA F:First Action
NOTIFICATION OF PRIORITY ACTION E-MAILED	2018-02-01	7 GPRN O:Outgoing Correspondence
EXAMINERS AMENDMENT -WRITTEN	2018-03-23	8 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2018-03-23	9 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2018-03-23	10 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2018-03-23	11 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-03-23	12 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-04-11	13 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2018-05-01	14 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2018-05-01	15 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2018-06-26	16 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2018-12-06	17 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2018-12-06	18 EXT1 S:
EXTENSION 1 GRANTED	2018-12-06	19 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2018-12-08	20 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-05-31	21 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2019-05-31	22 EXT2 S:
EXTENSION 2 GRANTED	2019-05-31	23 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-06-04	24 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-12-03	25 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2019-12-03	26 EXT3 S:
EXTENSION 3 GRANTED	2019-12-03	27 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-12-05	28 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2020-06-03	29 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2020-06-03	30 EXT4 S:
EXTENSION 4 GRANTED	2020-06-03	31 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-06-05	32 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2020-12-04	33 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2020-12-21	34 AITU A:Allowance for Publication
EXTENSION 5 FILED	2020-12-04	35 EXT5 S:
EXTENSION 5 GRANTED	2021-01-05	36 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2021-01-06	37 EXRA E:E-Mail
TEAS EXPRESS ABANDONMENT RECEIVED	2021-06-07	38 EXAR I:Incoming Correspondence
ABANDONMENT - AFTER PUBLICATION	2021-06-08	39 ABN5 O:Outgoing Correspondence
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION	2021-06-08	40 MAB5 E:E-Mail

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
NUOPTII 90785927 not registered Live/Pending	H. Lundbeck A/S 2021-06-21
NUOPTII 87650626 not registered Live/Pending	H. Lundbeck A/S 2017-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.